KRYS - Krystal Biotech added to Evercore's Tactical Outperform list on drug launch
2024-02-02 11:28:52 ET
More on Krystal Biotech
- Krystal Biotech's Vyjuvek Impresses Early On, Bolsters Prospects
- Krystal Biotech Inc. (KRYS) Q3 2023 Earnings Call Transcript
- Goldman starts Krystal Biotech at buy, cites Vyjuvek launch
- Seeking Alpha’s Quant Rating on Krystal Biotech
- Historical earnings data for Krystal Biotech